Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 8;3(9):1281-1282.
doi: 10.1002/hep4.1399. eCollection 2019 Sep.

Guidance for Safety and Dosing of Medicines in Patients With Cirrhosis Is Available

Rianne A Weersink  1   2 , Joost P H Drenth  3 , Nicole G M Hunfeld  4 , Sander D Borgsteede  2
Affiliations

Guidance for Safety and Dosing of Medicines in Patients With Cirrhosis Is Available

Rianne A Weersink et al. Hepatol Commun. .
No abstract available

PubMed Disclaimer

References

    1. Hayward KL, Patel PJ, Valery PC, Horsfall LU, Li CY, Wright PL, et al. Medication‐related problems in outpatients with decompensated cirrhosis: opportunities for harm prevention. Hepatol Commun 2019;3:620‐631. - PMC - PubMed
    1. Weersink RA, Bouma M, Burger DM, Drenth J, Harkes‐Idzinga SF, Hunfeld N, et al. Evidence‐based recommendations to improve the safe use of drugs in patients with liver cirrhosis. Drug Saf 2018;41:603‐613. - PMC - PubMed
    1. Démolis J, Angebaud P, Grangé J, Coates P, Funck‐Brentano C, Jaillon P. Influence of liver cirrhosis on sertraline pharmacokinetics. Br J Clin Pharmacol 1996;42:394‐397. - PMC - PubMed
    1. Weersink RA, Taxis K, Drenth J, Houben E, Metselaar HJ, Borgsteede SD. Prevalence of drug prescriptions and potential safety in patients with cirrhosis: a retrospective real‐world study. Drug Saf 2019;42:539‐546. - PMC - PubMed